1,800
Participants
Start Date
December 31, 2014
Primary Completion Date
August 31, 2017
Study Completion Date
August 31, 2017
Mailed Outreach Invitation
"Individuals randomized to Group 2 will receive:~1. Mailed outreach invitation to complete HCC screening ultrasound and alpha-fetoprotein (AFP) blood test.~2. Live phone calls 2 to 4 weeks after the mailed invitation to facilitate HCC screening completion. Up to three attempts will be made. All communications will use standard English or Spanish scripts.~3. Centralized process to promote guideline-appropriate follow up testing with CT or MRI or referral to GI Clinic."
Mailed Outreach Invitation and Patient Navigation
"Individuals randomized to Group 3 will receive:~1. Mailed outreach invitation to complete HCC screening ultrasound and alpha-fetoprotein (AFP) blood test.~2. Live phone calls 2 to 4 weeks after the mailed invitation to facilitate HCC screening completion and address patients' self-reported barriers to HCC screening (e.g., it does not apply to me). Up to three attempts will be made. All communications will use standard English or Spanish scripts.~3. Centralized navigation to promote screening completion (i.e., appointment reminder phone calls from patient navigator) and guideline-appropriate follow up testing with CT or MRI or referral to GI Clinic."
Parkland Health & Hospital System, Dallas
Agency for Healthcare Research and Quality (AHRQ)
FED
Parkland Health and Hospital System
OTHER
The University of Texas Health Science Center, Houston
OTHER
Johns Hopkins Bloomberg School of Public Health
OTHER
University of Texas Southwestern Medical Center
OTHER